HCM
VBIV

Highbridge Capital Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Highbridge Capital Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8,333
Closed -$875K – 1394
2018
Q1 		$875K Hold
8,333
– – 0.01% 542
2017
Q4 		$1.07M Buy
+8,333
New +$1.02M 0.02% 543

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Highbridge Capital Management's VBIV Position: Q2 2018 in Review

Highbridge Capital Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2018, closing a stake of 8,333 shares — an estimated $875K sold.

Highbridge Capital Management first reported a position in VBIV in Q4 2017 and held it in 2 quarters. The position peaked at $1.07M in Q4 2017. 48 funds tracked by Wall St. Rank hold VBIV as of Q2 2018.

  • Highbridge Capital Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 8,333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2018, an estimated $875K.
  • Highbridge Capital Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 2 quarters.
  • Highbridge Capital Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.07M in Q4 2017.
  • 48 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.